Cleerly, a Denver, CO-based company which specializes in advanced cardiovascular imaging, raised $106M in funding.
The round was led by Insight Partners and joined by Battery Ventures with participation from pre-existing investors.
The company intends to use the funds to scale its commercial growth and clinical evidence generation.
Led by James K. Min, MD, Founder and CEO, Cleerly provides FDA-cleared solutions driven by artificial intelligence, supporting comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Its approach is grounded in science, based on millions of medical images. The company enhances health literacy for stakeholders in the coronary care pathway.
FinSMEs
04/12/2024